IOSUD Doctoral School, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Târgu Mureş, Târgu Mureş, Romania.
"Dr. Constantin Papilian" Military Emergency Hospital Cluj-Napoca, Cluj-Napoca, Romania.
Rom J Ophthalmol. 2024 Apr-Jun;68(2):143-147. doi: 10.22336/rjo.2024.26.
This study aimed to investigate the potential connections between Alzheimer's Disease (AD) and diabetes. This is a cross-sectional study in which AD and diabetes patients sent by the Psychiatry and Diabetes Departments for ophthalmological screening were observed for inclusion/exclusion criteria. Patients were divided into two comparison groups. The first group (n=3) consisted of the age-matched normal and diabetic patient of the stage 3 AD disease participant. The second group (n=3) was for the stage 5 AD patient with diabetes and normal age-matched controls. Each patient underwent a full ophthalmological examination and SS-OCT (Swept Source-Ocular Computer Tomography) for retinal evaluation. A total of 6 patients (12 eyes) were obtained, three men and three women. In the early AD group, the patient with diabetes showed lower macular thickness compared to other groups. In the nasal-inferior (NI) and temporal-superior (TS) ganglion cell layer (GCL), the AD patient showed statistically significant lower values compared to the other patients. In the moderately severe AD group, we found that the AD patient had lower retinal nerve fiber layer (RNFL) thickness on the temporal side compared to the rest of the patients and both the AD patient and diabetes patient showed lower RNFL thickness in the nasal-superior (NS) quadrant. Also, the foveal avascular zone (FAZ) area was statistically significantly lower for both the diabetes and AD patients compared to the healthy control. In conclusion, distinct retinal findings associated with AD and diabetes in young and elderly patients were revealed in our study. The clinical implications and potential interplay between these conditions need to be elucidated by further research. AD = Alzheimer's Disease, SS-OCT = Swept Source - Ocular Computer Tomography, GCL = Ganglion cell layer, RNFL = Retinal nerve fiber layer, FAZ = foveal avascular zone.
本研究旨在探讨阿尔茨海默病(AD)与糖尿病之间的潜在联系。这是一项横断面研究,观察了由精神科和糖尿病科转来进行眼科筛查的 AD 和糖尿病患者是否符合纳入/排除标准。患者被分为两组进行比较。第一组(n=3)由年龄匹配的正常和 3 期 AD 疾病患者中的糖尿病患者组成。第二组(n=3)为 5 期 AD 合并糖尿病患者和年龄匹配的正常对照组。每位患者均接受全面眼科检查和 SS-OCT(扫频源眼部计算机断层扫描)视网膜评估。共获得 6 名患者(12 只眼),其中 3 名男性,3 名女性。在早期 AD 组中,糖尿病患者的黄斑厚度较其他组低。在鼻下方(NI)和颞上方(TS)神经节细胞层(GCL),AD 患者的数值明显低于其他患者。在中度严重 AD 组中,我们发现 AD 患者颞侧的视网膜神经纤维层(RNFL)厚度较其他患者低,AD 患者和糖尿病患者的鼻上方(NS)象限的 RNFL 厚度均较低。此外,糖尿病和 AD 患者的黄斑中心凹无血管区(FAZ)面积均明显小于健康对照组。总之,我们的研究揭示了年轻和老年 AD 患者与糖尿病相关的独特视网膜表现。需要进一步研究阐明这些情况之间的临床意义和潜在相互作用。AD=阿尔茨海默病,SS-OCT=扫频源-眼部计算机断层扫描,GCL=神经节细胞层,RNFL=视网膜神经纤维层,FAZ=黄斑中心凹无血管区。